COR Strangle Strategy
COR (Cencora, Inc.), in the Healthcare sector, (Medical - Distribution industry), listed on NYSE.
Cencora, Inc. functions as a global leader in the sourcing and distribution of pharmaceutical products, with operations spanning both the United States and international markets. Within its U.S. Healthcare Solutions segment, the company supplies a broad spectrum of pharmaceutical items, including generic and injectable medications, over-the-counter health products, and home healthcare equipment. Its extensive client network includes acute care hospitals, health systems, a variety of retail and mail-order pharmacies (independent, chain, long-term care), medical clinics, and other healthcare providers. This division also manages the distribution of crucial specialized pharmaceutical products like plasma, blood derivatives, and vaccines. Beyond product supply, Cencora offers comprehensive support services, such as pharmacy management, staffing solutions, and strategic consulting.
COR (Cencora, Inc.) trades in the Healthcare sector, specifically Medical - Distribution, with a market capitalization of approximately $55.67B, a trailing P/E of 21.84, a beta of 0.59 versus the broader market, a 52-week range of 244.82-377.54, average daily share volume of 1.8M, a public-listing history dating back to 1995, approximately 47K full-time employees. These structural characteristics shape how COR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.59 indicates COR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. COR pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.
What is a strangle on COR?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current COR snapshot
As of June 29, 2026, spot at $282.60, ATM IV 25.90%, IV rank 24.61%, expected move 7.43%. The strangle on COR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 18-day expiry.
Why this strangle structure on COR specifically: COR IV at 25.90% is on the cheap side of its 1-year range, which favors premium-buying structures like a COR strangle, with a market-implied 1-standard-deviation move of approximately 7.43% (roughly $20.98 on the underlying). The 18-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated COR expiries trade a higher absolute premium for lower per-day decay. Position sizing on COR should anchor to the underlying notional of $282.60 per share and to the trader's directional view on COR stock.
COR strangle setup
The COR strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With COR near $282.60, the first option leg uses a $300.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed COR chain at a 18-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 COR shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $300.00 | $1.00 |
| Buy 1 | Put | $270.00 | $1.70 |
COR strangle risk and reward
- Net Premium / Debit
- -$270.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$270.00
- Breakeven(s)
- $267.30, $302.70
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
COR strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on COR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$26,729.00 |
| $62.49 | -77.9% | +$20,480.67 |
| $124.98 | -55.8% | +$14,232.34 |
| $187.46 | -33.7% | +$7,984.01 |
| $249.94 | -11.6% | +$1,735.67 |
| $312.43 | +10.6% | +$972.66 |
| $374.91 | +32.7% | +$7,220.99 |
| $437.39 | +54.8% | +$13,469.32 |
| $499.88 | +76.9% | +$19,717.65 |
| $562.36 | +99.0% | +$25,965.98 |
When traders use strangle on COR
Strangles on COR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the COR chain.
COR thesis for this strangle
The market-implied 1-standard-deviation range for COR extends from approximately $261.62 on the downside to $303.58 on the upside. A COR long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current COR IV rank near 24.61% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on COR at 25.90%. As a Healthcare name, COR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to COR-specific events.
COR strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. COR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move COR alongside the broader basket even when COR-specific fundamentals are unchanged. Always rebuild the position from current COR chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on COR?
- A strangle on COR is the strangle strategy applied to COR (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With COR stock trading near $282.60, the strikes shown on this page are snapped to the nearest listed COR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are COR strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the COR strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 25.90%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$270.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a COR strangle?
- The breakeven for the COR strangle priced on this page is roughly $267.30 and $302.70 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current COR market-implied 1-standard-deviation expected move is approximately 7.43%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on COR?
- Strangles on COR are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the COR chain.
- How does current COR implied volatility affect this strangle?
- COR ATM IV is at 25.90% with IV rank near 24.61%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.